#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurodevelopmental disorder Primitive neuroectodermal tumour VEXAS syndrome Infertility male Liposarcoma Tuberous sclerosis complex Germ cell cancer Arginase deficiency Astrocytoma Hyperinsulinism Neonatal asphyxia Prodromal Alzheimer's disease Mantle cell lymphoma stage IV Lennox-Gastaut syndrome Hereditary hypophosphataemic rickets More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Trials in Disease Combined immunodeficiency – Treatment Retinoblastoma Myelodysplastic syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria Congenital generalised lipodystrophy Rosai-Dorfman syndrome – Basic Information Loeys-Dietz syndrome – Trials in Disease Urea cycle disorder – Life with Disease Mastocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rizolipase Ribonucleic Acid K30 Noradrenaline Tartrate Camphor Alxn2220 Glucose, Anhydrous Atl001 Magnesium Oxide, Light Etuvetidigene Autotemcel Tofersen Betahistine Dihydrochloride Clascoterone Gabapentin Pyrimethamine ANXV Autologous Chondrocytes Peginterferon Alfa-2A Protease Ima402 SURVODUTIDE More therapies…

    Learn about Your Condition

    Carotid artery stenosis Gastric cancer stage IV Skin bacterial infection C3 glomerulopathy Immune-mediated enterocolitis Ulcerative keratitis Tumour of ampulla of Vater Aortic valve stenosis Proteus syndrome Cholangiosarcoma Hyperglycaemia Cognitive disorder Endometrial cancer stage II Bacterial prostatitis Electronic cigarette user More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia (in remission)
    Investigated Drugs:
    • Decitabine
    • Venetoclax
    Italy

  • Study of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypereosinophilic syndrome
    Investigated Drugs:
    • Benralizumab
    Austria Belgium Denmark France Germany Italy +3

  • Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Imatinib
    • Nilotinib
    Italy The Netherlands

  • Study on the Effectiveness and Safety of Mitapivat in Children with Pyruvate Kinase Deficiency Not Receiving Regular Blood Transfusions

    Not recruiting

    3 1
    Investigated Diseases:
    • Pyruvate kinase deficiency anaemia
    Investigated Drugs:
    • Mitapivat
    France Germany Italy The Netherlands Spain

  • Study on the Effects of Sapablursen for Patients with Phlebotomy Dependent Polycythemia Vera

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Sapablursen
    Poland

  • Study on Apixaban for Patients with Intrahepatic Non-Cirrhotic Portal Hypertension

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    France
Previous Page
1 … 74 75 76 77 78 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!